
Filler vs Biostimulator vs Skin Booster: Which Do You Need?
Three families of injectables are often confused because they can share ingredients. Dr Sin Yong explains what each is for at IN Eternity Clinic on Orchard Road, and why the concern, not the product, comes first.
Treatment page: skin boosters in Singapore.
WhatsApp to Enquire →Key facts ↓Dermal fillers, usually cross-linked hyaluronic acid, add shape on the day and can be dissolved. A biostimulator, also called a collagen stimulator, such as Sculptra, Radiesse or Ellansé, prompts your own collagen over months and cannot be dissolved. Skin boosters improve hydration, texture and fine lines without changing shape. Which you need depends on whether the problem is structure or skin quality.
Reversibility differs: only HA can be dissolved; see dissolving filler.
On this page
Injecting collagen itself, as Linerase does, is a different approach; see Linerase explained.
- Dermal filler: usually hyaluronic acid cross-linked into a gel of chosen firmness; it holds water and occupies space, giving immediate volume or definition.
- Biostimulator: particles such as poly-L-lactic acid, calcium hydroxylapatite or polycaprolactone that prompt fibroblasts to lay down new collagen around them.
- Skin booster: lightly or non-cross-linked hyaluronic acid, polynucleotides or similar, placed in the dermis to improve hydration, texture and fine lines.
- Shape vs quality: fillers and some biostimulators change shape; skin boosters do not and are not meant to.
- Reversibility: hyaluronic acid can be dissolved with hyaluronidase; biostimulator particles cannot.
- Speed: fillers show on the day; skin boosters over a course of weeks; biostimulators over months.
- Safety: all injectables carry a small risk of vascular complications; risk is highest with volumising products in high-risk areas.
- Planning: existing product is mapped with ultrasound before more is added, so new product is not layered on old.
- Biostimulator longevity: poly-L-lactic acid (Sculptra) effects were reported up to 25 months in a randomised trial of 233 people. (Source: Narins 2010)
- Structural stimulator longevity: a polycaprolactone (Ellansé-type) formulation sustained improvement through a 24-month randomised trial. (Source: Moers-Carpi 2013)
- Biostimulator safety: across 5,081 calcium hydroxylapatite (Radiesse) treatments, 173 adverse events were reported, nearly all nodules. (Source: Kadouch 2017)
- Skin booster safety: a systematic review of Profhilo (nine studies, 278 people) found adverse events mild and usually resolved within 72 hours. (Source: Sparavigna 2026)
- Filler and vision: 98 cases of vision change after filler were found in the world literature up to 2015, most often after fat or hyaluronic acid in the glabella, nose, nasolabial fold or forehead. (Source: Beleznay 2015)
What is the difference between them?
Dermal fillers are gels, most often hyaluronic acid (HA) that has been chemically cross-linked so it lasts longer and holds a shape. Placed under the skin or near bone, they occupy space and attract water, giving immediate volume or definition: a cheekbone, a chin, a softened hollow, lips. Because they are HA, they can be broken down with hyaluronidase if needed.
Biostimulators are biodegradable particles that the body walls off, laying down collagen around them. Poly-L-lactic acid (for example Sculptra) gives little lasting day-one volume and builds collagen slowly. Calcium hydroxylapatite (for example Radiesse) and polycaprolactone (for example Ellansé) give immediate support from a gel carrier, followed by collagen. None can be dissolved with hyaluronidase.
Skin boosters act on the quality of the skin rather than its shape. They include lightly cross-linked or non-cross-linked HA placed as tiny droplets in the dermis, high-concentration HA that spreads through the tissue (for example Profhilo), and polynucleotides (for example Rejuran). The aims are hydration, a smoother texture, softer fine lines and better resilience.

Filler vs biostimulator vs skin booster compared
| Filler | Biostimulator | Skin booster | |
|---|---|---|---|
| Main job | Shape and volume | Collagen scaffold | Skin quality |
| When it shows | Same day | Over months | Over a course of weeks |
| Depth | Deep or subcutaneous | Deep or subcutaneous; diluted in dermis | Dermis |
| Dissolvable | Yes, if HA | No | HA types, yes |
| Typical uses | Cheek, chin, lips, hollows | Gradual volume loss, structure | Dryness, crepiness, texture |
Some products sit across categories: diluted calcium hydroxylapatite, for example, is used for skin quality rather than shape.
“The first question is not which product, but which problem: shape or skin. Most injectable disappointments come from answering the second question first.”
Why choosing the wrong family causes problems
Most disappointing injectable results come from using one family to do another’s job. Filler used to fix crepey skin adds weight without improving texture. Repeated filler to chase sagging can make a face wider and heavier, a pattern sometimes called pillow face. A skin booster given to someone who has lost structure in the mid-face will improve the skin but not the shape, and the person may feel the treatment did nothing.
Biostimulators have their own trap: because they cannot be dissolved and the result develops slowly, adding more because nothing seems to have happened after two weeks risks overcorrection months later. The safeguard is to define the concern clearly at the start, choose the family that addresses it, and review the result on the timetable that product actually works to.

How to tell which one you need
A practical test is to ask what has changed. If the face has lost shape, such as flatter cheeks, a receding chin, hollow temples or a less defined jawline, the problem is structure, and filler or a biostimulator is usually the answer. Filler suits someone who wants a defined change on the day and the option to reverse it. A biostimulator suits someone who prefers gradual change and accepts that it cannot be dissolved.
If the shape is fine but the skin looks dry, dull, crepey or slow to recover, the problem is quality, and a skin booster is the more direct tool. Many faces have both, and a staged plan restores support first and then works on the skin, or vice versa, with time between steps to judge each one.
Some concerns suit none of these. Pigmentation, redness, active acne and significant sagging with skin excess have their own treatments, and Dr Sin Yong will say when an injectable is not the answer.
Stage of life also shapes the choice. In the thirties, the first changes are often in skin quality and small areas of volume, so boosters and small, precise amounts of filler are common starting points. Later, broader volume loss and changes in bone support make gradual collagen stimulation and structural support more relevant. These are tendencies, not rules; the face in front of the doctor decides.
How Dr Sin Yong plans injectables
Every injectable plan at IN Eternity Clinic starts with an examination at rest and on expression, a history of what has been injected before, and, where earlier filler is present or suspected, an ultrasound scan to see where it sits. Many people seeking more volume actually have older product that has spread or been layered. In that case correction comes first.
Dr Sin Yong keeps doses conservative and reviews each step before the next. For structural work on the nose, chin and jawline he usually prefers a structural product such as calcium hydroxylapatite or polycaprolactone over hyaluronic acid alone. For skin quality, the choice between HA boosters, Profhilo and polynucleotides depends on whether the skin is mainly dehydrated, lax or fragile.
Risks across all three
Swelling, bruising and tenderness are common after any injection and usually settle within days. Lumps can occur, more often with superficial placement or with particle-based products. The rare but serious risk is product entering or compressing a blood vessel, which can damage skin or, very rarely, affect vision. It is more likely with volumising products in certain areas, such as around the nose and between the eyebrows.
This is why anatomy, technique, cannula or needle choice and an emergency plan matter, and why hyaluronidase is kept on hand. Sudden pain, blanching, a dusky patch or any change in vision after an injection needs same-day medical attention. Injectables are avoided during pregnancy and breastfeeding and over active skin infection.
What does treatment feel like, and what follows?
Numbing cream is applied first, and many fillers contain local anaesthetic. Filler and biostimulator injections are felt as pressure and a brief sting; skin boosters, placed as many small droplets, feel like quick pinpricks. Most appointments take thirty to sixty minutes including numbing.
Afterwards, filler and biostimulator areas may be swollen for several days, and bruising can take a week to fade. Skin boosters usually leave small bumps that settle within hours to a day or two. Makeup is generally possible the next day. Heavy exercise, saunas and facial massage are avoided for a short period unless massage is specifically advised for the product used. A review is planned to assess the result at the right time for the product.
How long does each injectable family last in studies?
Fillers show on the day and last for a period that varies with the gel, biostimulators build over months and have been followed for about two years, and skin boosters work over a course of weeks with shorter study follow-up.
| Product (substance) | How it works | When change shows | What the cited studies report | Usual sessions |
|---|---|---|---|---|
| Hyaluronic acid filler | Cross-linked gel that holds water and occupies space | On the day | Varies with the gel and the area; can be dissolved with hyaluronidase | Usually one, with review |
| Sculptra (poly-L-lactic acid, PLLA) | Particles prompt new collagen around them; little lasting day-one volume | Gradually, over about three months after the last session | Effects reported up to 25 months in a randomised trial of 233 people (Narins 2010) | Often two or three, weeks apart |
| Radiesse (calcium hydroxylapatite, CaHA) | Gel carrier supports on the day; microspheres then prompt collagen | Shape on the day; collagen over months | A 12-month randomised split-face trial against hyaluronic acid (Moers-Carpi 2008); new collagen on biopsy at six months (Berlin 2008) | Often one, with review; diluted plans may use more |
| Ellansé (polycaprolactone, PCL) | Gel carrier supports on the day; microspheres then prompt collagen | Shape on the day; collagen over weeks to months | Improvement maintained to 24 months with the longer-lasting formulation (Moers-Carpi 2013) | Often one, with review |
| Juvelook (poly-D,L-lactic acid, PDLLA, with HA) | Porous microspheres in the dermis prompt collagen; the HA hydrates briefly | Over weeks to months; early plumpness fades first | Safety follow-up to 24 months (No 2015); skin measures at six months in 15 women (J Med Assoc Thai 2025) | Often two or three, four to six weeks apart |
| Profhilo (hybrid high- and low-molecular-weight HA) | Spreads through the dermis and binds water | Over a few weeks | 16 weeks in 64 women (Sparavigna 2016); nine studies with 278 people reviewed (Sparavigna 2026) | Usually two, four weeks apart |
Two cautions in reading it. The studies are separate, in different people and areas, so they show how long each product has been followed rather than ranking them. And longer-lasting is a trade-off, not a prize: the products that last longest are the ones that cannot be dissolved. The owner pages go further: dermal fillers in Singapore, collagen injection in Singapore for biostimulators, and skin booster Singapore.
What are the side effects and complications of fillers, biostimulators and skin boosters?
All three share short-lived swelling, bruising and tenderness; lumps are more often seen with particle-based biostimulators, and vascular events are rare but most linked to volumising filler in high-risk areas.
| Family | Common | Main complication | Can it be dissolved? | Deeper guide |
|---|---|---|---|---|
| Hyaluronic acid filler | Swelling, bruising for days | Lumps, migration, Tyndall tint; rarely vascular occlusion | Yes, with hyaluronidase | filler complications |
| Biostimulator | Swelling, tenderness, bruising | Nodules, sometimes months later | No | collagen stimulator side effects |
| Skin booster | Small bumps for one to three days | Persistent bumps; PDLLA nodules | Hyaluronic acid types, yes | skin booster side effects |
The difference in reversibility shapes the plan. Where small errors would show, such as the lips and under the eyes, hyaluronic acid is usually preferred because it can be dissolved. Biostimulators are kept deep and dosed conservatively because they cannot. Warning signs of a blocked vessel, and what a clinic should have ready, are explained in vascular occlusion after filler.
When to act at once. If you notice blanching (skin turning pale or white), severe or increasing pain, mottled or dusky skin, or any change in vision after an injection, contact the treating clinic immediately. For any change in vision, go to the nearest emergency department. Do not try to treat it yourself or wait to see if it settles.
At IN Eternity Clinic, Dr Sin Yong performs injectable treatments himself, maps earlier filler with ultrasound where it is useful, and the clinic keeps an emergency protocol for vascular events, with hyaluronidase on hand for hyaluronic acid filler. How the clinic prepares is set out on safety and sterilisation.
Common myths, answered
- Myth: Skin boosters are a lighter version of filler.
Fact: They are designed for a different job. Skin boosters improve skin quality and do not add shape; fillers add shape and do little for texture. - Myth: All fillers can be dissolved.
Fact: Hyaluronidase dissolves hyaluronic acid only. Calcium hydroxylapatite, polycaprolactone and poly-L-lactic acid are not dissolved by it. - Myth: Biostimulators show results straight away.
Fact: Some give early volume from their carrier gel, but the collagen effect develops over weeks to months. - Myth: If one syringe helps, more is always better.
Fact: Overfilling is a common cause of heaviness. Smaller, reviewed steps give more natural results.
Frequently asked questions
What is the difference between a filler and a skin booster?
A filler is usually a cross-linked hyaluronic acid gel that adds shape and volume where it is placed. A skin booster is placed in the dermis to improve hydration, texture and fine lines without changing shape. They solve different problems and are sometimes used together in a staged plan.
What is a biostimulator?
A biostimulator is an injectable containing biodegradable particles, such as poly-L-lactic acid, calcium hydroxylapatite or polycaprolactone, that prompt your skin to lay down new collagen around them. The change develops over weeks to months, and the particles cannot be dissolved with hyaluronidase.
Which lasts longest?
It varies with the product, the area and the person. Biostimulators and some fillers can last a year or more; skin boosters usually need maintenance sessions. Longevity is discussed for your plan at consultation, because metabolism, movement and lifestyle all affect it.
Can I have filler and a skin booster at the same time?
Sometimes, but they are often spaced apart so each can be assessed on its own and swelling from one does not hide the effect of the other. Dr Sin Yong decides the order and timing based on your concerns, skin and any previous treatments.
How much do fillers, biostimulators and skin boosters cost?
Cost depends on the product family and brand, the number of syringes or vials needed, the number of sessions and whether ultrasound mapping or correction of old filler comes first. After assessment, Dr Sin Yong gives a written quote listing each part of the plan.
Are skin boosters safe?
They are generally well tolerated, with small bumps, mild swelling and occasional bruising. As with any injection, infection and lumps are possible but uncommon. Your history, allergies and medicines are reviewed beforehand, and treatment is avoided during pregnancy, breastfeeding or active skin infection.
Why do you scan before adding filler?
Because many people have older filler that has spread or been layered, and adding more on top can make the face heavier. Ultrasound shows where existing product sits and how deep, so the plan can correct, avoid or work around it before anything new is placed.
Is a biostimulator the same as a collagen stimulator?
Yes, the two terms are used for the same family: injectables such as poly-L-lactic acid (Sculptra), calcium hydroxylapatite (Radiesse) and polycaprolactone (Ellansé) that prompt your own collagen around biodegradable particles. Some writers also include PDLLA products such as Juvelook. None of them can be dissolved with hyaluronidase.
Is Profhilo a filler or a skin booster?
A skin booster. Profhilo is a high concentration of hybrid hyaluronic acid that spreads through the skin to improve hydration and firmness; it does not add shape at a chosen point. Its deeper relative, Profhilo Structura, is placed in the fat at the side of the face but is still not a volumising filler. See Profhilo in Singapore.
Is Juvelook a skin booster or a biostimulator?
It sits between the two. Juvelook is placed in the skin like a booster, for texture and quality rather than shape, but its PDLLA acts as a collagen stimulator over months. That is why only its hyaluronic acid part can be dissolved and why it is dosed cautiously. More on Juvelook in Singapore.
Which injectable is used for acne scars?
For shallow, rolling scars and crepey texture, skin boosters and PDLLA can help by improving the skin around the scar. Deeper or tethered scars need other steps first, such as subcision, TCA CROSS or laser, and fillers are used only occasionally for selected depressed scars. The full plan is set out on acne scar treatment in Singapore.
Can I switch from filler to a biostimulator?
Often, yes, but existing filler is mapped with ultrasound first. Placing a biostimulator over hyaluronic acid that has spread or built up can make the face heavier, so older product may be dissolved or left to settle before anything new is added. The order is set at assessment.
Which injectable family carries the most risk?
Each has its own pattern. Vascular events are rare with all three but are most linked to volumising filler in areas such as the glabella and nose. Biostimulators carry a higher chance of nodules and cannot be dissolved. Skin boosters usually cause only short-lived bumps. Technique, anatomy and conservative amounts matter more than the family itself.
Book an assessment
IN Eternity Clinic, 9 Scotts Road, #12-01 Pacific Plaza, Singapore 228210. By appointment with Medical Director Dr Sin Yong. Monday to Saturday, 11am to 8pm. WhatsApp or call +65 8815 3008.
International KOL — CLASSYS · HIRONIC · DEKA · ALMA · FOTONA · LUTRONIC
References
- Schelke LW, Decates TS, Velthuis PJ. Ultrasound to improve the safety of hyaluronic acid filler treatments. J Cosmet Dermatol 2018;17(6):1019-1024. doi:10.1111/jocd.12726
- Vleggaar D. Soft-tissue augmentation and the role of poly-L-lactic acid. Plast Reconstr Surg 2006;118(3 Suppl):46S-54S. doi:10.1097/01.prs.0000234846.00139.74
- Christen MO, Vercesi F. Polycaprolactone: How a Well-Known and Futuristic Polymer Has Become an Innovative Collagen-Stimulator in Esthetics. Clin Cosmet Investig Dermatol 2020;13:31-48. doi:10.2147/CCID.S229054
- Kerscher M, Bayrhammer J, Reuther T. Rejuvenating influence of a stabilized hyaluronic acid-based gel of nonanimal origin on facial skin aging. Dermatol Surg 2008;34(5):720-726. doi:10.1111/j.1524-4725.2008.34176.x
- Beleznay K, Carruthers JDA, Humphrey S, Jones D. Avoiding and Treating Blindness From Fillers: A Review of the World Literature. Dermatol Surg 2015;41(10):1097-1117. doi:10.1097/DSS.0000000000000486
- Narins RS, Baumann L, Brandt FS, et al. A randomized study of the efficacy and safety of injectable poly-L-lactic acid versus human-based collagen implant in the treatment of nasolabial fold wrinkles. J Am Acad Dermatol 2010;62(3):448-462. doi:10.1016/j.jaad.2009.07.040
- Moers-Carpi MM, Sherwood S. Polycaprolactone for the correction of nasolabial folds: a 24-month, prospective, randomized, controlled clinical trial. Dermatol Surg 2013;39(3 Pt 1):457-463. doi:10.1111/dsu.12054
- Moers-Carpi MM, Tufet JO. Calcium hydroxylapatite versus nonanimal stabilized hyaluronic acid for the correction of nasolabial folds: a 12-month, multicenter, prospective, randomized, controlled, split-face trial. Dermatol Surg 2008;34(2):210-215. doi:10.1111/j.1524-4725.2007.34039.x
- Berlin AL, Hussain M, Goldberg DJ. Calcium hydroxylapatite filler for facial rejuvenation: a histologic and immunohistochemical analysis. Dermatol Surg 2008;34 Suppl 1:S64-S67. doi:10.1111/j.1524-4725.2008.34245.x
- Kadouch JA. Calcium hydroxylapatite: a review on safety and complications. J Cosmet Dermatol 2017;16(2):152-161. doi:10.1111/jocd.12326
- Sparavigna A, Tenconi B. Efficacy and tolerance of an injectable medical device containing stable hybrid cooperative complexes of high- and low-molecular-weight hyaluronic acid: a monocentric 16 weeks open-label evaluation. Clin Cosmet Investig Dermatol 2016;9:297-305. doi:10.2147/CCID.S114450
- Sparavigna A, Cigni C, Tanzini L, et al. A systematic review of the efficacy and safety of Profhilo and Profhilo Body. Plast Aesthet Nurs (Phila) 2026;46(2):80-92. doi:10.1097/PSN.0000000000000637
- No YA, Seok J, Hyun MY, et al. Long-term (24-month) safety evaluation of poly-DL-lactic acid filler injection for the nasolabial fold. Plast Reconstr Surg 2015;135(6):1074e-1075e. doi:10.1097/PRS.0000000000001247
- Effect of poly-D,L-lactic acid (PDLLA) biostimulator on facial rejuvenation markers in late middle-aged Thai women: a quasi-experimental study. J Med Assoc Thai 2025. doi:10.35755/jmedassocthai.2025.6.457-463-02252
These sources describe mechanisms and general evidence. They are not a promise of any individual result; suitability is decided at an in-person assessment.